AMIX Financials

Income Statement
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
2.8M
+1.2%
2.7M
-18.1%
3.3M
-55.6%
7.5M
+120.2%
3.4M
R&D
1.5M
+3.8%
1.5M
-15.3%
1.7M
-27.2%
2.4M
+48.6%
1.6M
SG&A
1.3M
-1.7%
1.3M
-21.1%
1.6M
-68.7%
5.2M
+182.7%
1.8M
Operating Income
-2770000
-1.2%
-2737000
+18.1%
-3343000
+55.6%
-7534000
-120.2%
-3421000
EBITDA
-2767000
-1.2%
-2734000
+18.1%
-3339000
+55.7%
-7532000
-120.4%
-3418000
Net Income
-2728000
-2.3%
-2666000
+18.2%
-3261000
+56.2%
-7451000
-123.3%
-3337000
EPS (Basic)
$-5.02
-28.7%
$-3.90
+48.4%
$-7.56
+73.9%
$-28.98
-27.7%
$-22.69
EPS (Diluted)
$-5.02
-28.7%
$-3.90
+48.4%
$-7.56
+73.9%
$-28.98
-27.7%
$-22.69
Shares (Diluted)
543.7K
-20.4%
683.5K
+60.3%
426.5K
+65.5%
257.7K
+75.2%
147.1K
Autonomix Medical (AMIX) โ€” Financials